139 related articles for article (PubMed ID: 18501614)
1. Structure-activity relationships of a peptide inhibitor of the human FcRn:human IgG interaction.
Mezo AR; McDonnell KA; Castro A; Fraley C
Bioorg Med Chem; 2008 Jun; 16(12):6394-405. PubMed ID: 18501614
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of dimeric peptide antagonists of the human immunoglobulin G-human neonatal Fc receptor (IgG-FcRn) interaction.
McDonnell KA; Low SC; Hoehn T; Donnelly R; Palmieri H; Fraley C; Sakorafas P; Mezo AR
J Med Chem; 2010 Feb; 53(4):1587-96. PubMed ID: 20092334
[TBL] [Abstract][Full Text] [Related]
3. X-ray crystal structures of monomeric and dimeric peptide inhibitors in complex with the human neonatal Fc receptor, FcRn.
Mezo AR; Sridhar V; Badger J; Sakorafas P; Nienaber V
J Biol Chem; 2010 Sep; 285(36):27694-701. PubMed ID: 20592032
[TBL] [Abstract][Full Text] [Related]
4. The conserved histidine 166 residue of the human neonatal Fc receptor heavy chain is critical for the pH-dependent binding to albumin.
Andersen JT; Dee Qian J; Sandlie I
Eur J Immunol; 2006 Nov; 36(11):3044-51. PubMed ID: 17048273
[TBL] [Abstract][Full Text] [Related]
5. Albumin binding to FcRn: distinct from the FcRn-IgG interaction.
Chaudhury C; Brooks CL; Carter DC; Robinson JM; Anderson CL
Biochemistry; 2006 Apr; 45(15):4983-90. PubMed ID: 16605266
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the complex of rat neonatal Fc receptor with Fc.
Burmeister WP; Huber AH; Bjorkman PJ
Nature; 1994 Nov; 372(6504):379-83. PubMed ID: 7969498
[TBL] [Abstract][Full Text] [Related]
7. Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR.
Suzuki T; Ishii-Watabe A; Tada M; Kobayashi T; Kanayasu-Toyoda T; Kawanishi T; Yamaguchi T
J Immunol; 2010 Feb; 184(4):1968-76. PubMed ID: 20083659
[TBL] [Abstract][Full Text] [Related]
8. Discovery and structure-activity relationships of small molecules that block the human immunoglobulin G-human neonatal Fc receptor (hIgG-hFcRn) protein-protein interaction.
Wang Z; Fraley C; Mezo AR
Bioorg Med Chem Lett; 2013 Mar; 23(5):1253-6. PubMed ID: 23375228
[TBL] [Abstract][Full Text] [Related]
9. FcRn binding properties of an abnormal truncated analbuminemic albumin variant.
Andersen JT; Daba MB; Sandlie I
Clin Biochem; 2010 Mar; 43(4-5):367-72. PubMed ID: 20006594
[TBL] [Abstract][Full Text] [Related]
10. Identification of critical IgG binding epitopes on the neonatal Fc receptor.
Vaughn DE; Milburn CM; Penny DM; Martin WL; Johnson JL; Bjorkman PJ
J Mol Biol; 1997 Dec; 274(4):597-607. PubMed ID: 9417938
[TBL] [Abstract][Full Text] [Related]
11. Engineering human IgG1 affinity to human neonatal Fc receptor: impact of affinity improvement on pharmacokinetics in primates.
Yeung YA; Leabman MK; Marvin JS; Qiu J; Adams CW; Lien S; Starovasnik MA; Lowman HB
J Immunol; 2009 Jun; 182(12):7663-71. PubMed ID: 19494290
[TBL] [Abstract][Full Text] [Related]
12. FcRn mediates elongated serum half-life of human IgG in cattle.
Kacskovics I; Kis Z; Mayer B; West AP; Tiangco NE; Tilahun M; Cervenak L; Bjorkman PJ; Goldsby RA; Szenci O; Hammarström L
Int Immunol; 2006 Apr; 18(4):525-36. PubMed ID: 16481343
[TBL] [Abstract][Full Text] [Related]
13. An FcgammaRIIa-binding peptide that mimics the interaction between FcgammaRIIa and IgG.
Cendron AC; Wines BD; Brownlee RT; Ramsland PA; Pietersz GA; Hogarth PM
Mol Immunol; 2008 Jan; 45(2):307-19. PubMed ID: 17673295
[TBL] [Abstract][Full Text] [Related]
14. Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn.
Mezo AR; McDonnell KA; Hehir CA; Low SC; Palombella VJ; Stattel JM; Kamphaus GD; Fraley C; Zhang Y; Dumont JA; Bitonti AJ
Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2337-42. PubMed ID: 18272495
[TBL] [Abstract][Full Text] [Related]
15. A strategy for bacterial production of a soluble functional human neonatal Fc receptor.
Andersen JT; Justesen S; Berntzen G; Michaelsen TE; Lauvrak V; Fleckenstein B; Buus S; Sandlie I
J Immunol Methods; 2008 Feb; 331(1-2):39-49. PubMed ID: 18155020
[TBL] [Abstract][Full Text] [Related]
16. Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport.
Leach JL; Sedmak DD; Osborne JM; Rahill B; Lairmore MD; Anderson CL
J Immunol; 1996 Oct; 157(8):3317-22. PubMed ID: 8871627
[TBL] [Abstract][Full Text] [Related]
17. Field flow fractionation for assessing neonatal Fc receptor and Fcγ receptor binding to monoclonal antibodies in solution.
Pollastrini J; Dillon TM; Bondarenko P; Chou RY
Anal Biochem; 2011 Jul; 414(1):88-98. PubMed ID: 21385563
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the interactions of rabbit neonatal Fc receptor (FcRn) with rabbit and human IgG isotypes.
Szikora B; Hiripi L; Bender B; Kacskovics I; Iliás A
PLoS One; 2017; 12(9):e0185662. PubMed ID: 28957416
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies with identical Fc sequences can bind to FcRn differentially with pharmacokinetic consequences.
Wang W; Lu P; Fang Y; Hamuro L; Pittman T; Carr B; Hochman J; Prueksaritanont T
Drug Metab Dispos; 2011 Sep; 39(9):1469-77. PubMed ID: 21610128
[TBL] [Abstract][Full Text] [Related]
20. Ligand binding and antigenic properties of a human neonatal Fc receptor with mutation of two unpaired cysteine residues.
Andersen JT; Justesen S; Fleckenstein B; Michaelsen TE; Berntzen G; Kenanova VE; Daba MB; Lauvrak V; Buus S; Sandlie I
FEBS J; 2008 Aug; 275(16):4097-110. PubMed ID: 18637944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
